HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M E González Selected Research

Methotrexate (Mexate)

6/2001Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M E González Research Topics

Disease

2Giardiasis
12/2010 - 04/2008
1Wiskott-Aldrich Syndrome
02/2015
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2015
1Neoplasms (Cancer)
10/2012
1Virus Diseases (Viral Diseases)
01/2011
1Infections
12/2010
1Helminthiasis (Helminthiases)
05/2009
1Parasitic Diseases (Parasitic Disease)
05/2009
1Enterobiasis
05/2009
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2001
1Central Nervous System Diseases (CNS Diseases)
06/2001

Drug/Important Bio-Agent (IBA)

1Metronidazole (Metric)FDA LinkGeneric
12/2010
1Chloroquine (Aralen)FDA LinkGeneric
12/2010
1benzimidazoleIBA
05/2009
1CarbamatesIBA
05/2009
1Pharmaceutical PreparationsIBA
05/2009
1Mebendazole (Anti-Worm)FDA Link
05/2009
14-nitroimidazoleIBA
04/2008
1nitazoxanide (NTZ)FDA Link
04/2008
1TinidazoleFDA Link
04/2008
1Methotrexate (Mexate)FDA LinkGeneric
06/2001

Therapy/Procedure

1Stem Cell Transplantation
02/2015
1Radiotherapy
10/2012
1Cell Transplantation
01/2011
1Consolidation Chemotherapy
06/2001